ipamorelin 6mg/cjc1295 6mg CJC1295/Ipamorelin (No DAC) Ipamorelin/CJC-1295 (w/o DAC) - Simple

doi: 10.1002/mrm.21302

Hartl J, Ehlken H, Sebode M, et al

For patients with lymphoma, eligible patients with primary CNS lymphoma (PCNSL) were enrolled under the study NCT02203526, while patients with aggressive B cell lymphomas with secondary involvement of the CNS (sCNSL), untreated or relapsed/refractory disease, or untreated B cell lymphoma with CNS involvement were enrolled under the study NCT03964090

This review summarizes known ALDH inhibitors, their mechanisms of action, isozyme selectivity, potency, and clinical uses

Anemia: Especially B12-deficiency anemia can improve with Neurobion injectable therapy

Salmern-Brcenas et al